Publication list

Radin JM, Katz MA, Tempia S, Talla Nzussouo N, Davis R, Duque J, Adedeji A, Adjabeng MJ, Ampofo WK, Ayele W, Bakamutumaho B, Barakat A, Cohen AL, Cohen C,Dalhatu IT, Daouda C, Dueger E, Francisco M, Heraud JM, Jima D, Kabanda A, Kadjo H, Kandeel A, Bi Shamamba SK, Kasolo F, Kronmann KC, Mazaba Liwewe ML, Lutwama JJ, Matonya M, Mmbaga V, Mott JA, Muhimpundu MA, Muthoka P, Njuguna H, Randrianasolo L, Refaey S, Sanders C, Talaat M, Theo A, Valente F, Venter M, Woodfill C, Bresee J, Moen A, Widdowson MA. Influenza surveillance in 15 countries in Africa, 2006-2010. J Infect Dis. 2012 Dec;206 Suppl 1:S14-21.

Zaayman D, Venter M. West Nile virus neurologic disease in humans, South Africa, September 2008–May 2009. EID 2012 18: 2051-2054.

Braack, L.E.O., and Pont, A.C.. Rediscovery of Haematobosca zuluensis (Zumpt), (Diptera, Stomoxyinae): Re-description and amended keys for the genus. Parasites & Vectors, 5:267. DOI 2012: 10.1186/1756-3305-5-267.

Madhi SA, Dittmer S, Kuwanda L, Venter M, Cassim H, Lazarus E, Thomas T, Liberty A, Treurnich F, Cutland CL, Weinberg A, Violari A. Efficacy and immunogenicity of influenza vaccine in HIV-infected children: A randomized, double-blind, placebo controlled trial. AIDS. 2012 Oct 1.

Van Eeden C, Williams, JH Gerdes TGH, van Wilpe E, Viljoen A, Swanepoel R, Venter M. Shuni Virus as Cause of Neurological Disease in Horses in Africa. (Emerging Infectious Diseases, available online Feb 2012)(Impact factor 6)

Nair H, Brooks WA , Mark Katz M, Roca A , Berkley JA , Madhi SA, Simmerman JM, Aubree Gordon A, Sato M, Howie S, Krishnan A ,Ope M , Lindblade KA, Carosone-Link P, Lucero M , Ochieng W, Kamimoto L, Dueger E, Bhat N, Vong S, Theodoratou E,Chittaganpitch M, Osaretin Chimah O,Balmaseda A, Buchy P, Harris E, Evans V, Katayose M, Gaur B, O’Callaghan-Gordo C, Goswami D, Arvelo W, Venter M, Briese T, Tokarz R, Widdowson M, Mounts AW , Breiman RF, Da Feikin DR , Klugman KP, Olsen SJ, Gessner BD , Wright PF, Rudan I , Broor S , Simões EA , Campbell H, The global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet. 2011 Dec 3;378(9807):1917-30 (Impact factor 33)

Pretorius MA; Madhi SA; Cohen C; Naidoo D; Groome M; Moyes J; Buys A; Walaza S, Dawood H; Chhagan M; Haffjee S; Kahn K; Puren A; Venter M. Prevalence of respiratory viral co-infections in South Africans hospitalized for Severe Acute Respiratory Illness during 2009 and 2010. J. Infectious Diseases, in press.

Venter M, Naidoo D, Pretorius MA, Treurnicht F Buys A, McAnerney J Blumberg L, Madhi SA, Cohen C, Schoub BD. Evolutionary dynamics of Pandemic H1N1/09 in South Africa from 2009-2010. J. Infectious Diseases, in press. (Impact factor 5)

Pretorius MA; Shabir A. Madhi; Cheryl Cohen; Dhamari Naidoo; Michelle Groome; Jocelyn Moyes; Amelia Buys; Sibongile Walaza; Halima Dawood; Meera Chhagan; Sumayya Haffjee; Kathleen Kahn; Adrian Puren; Marietjie Venter. Respiratory Viral Coinfections Identified by a 10-Plex Real-Time Reverse-Transcription Polymerase Chain Reaction Assay in Patients Hospitalized With Severe Acute Respiratory IllnessSouth Africa, 2009-2010. JID 2012 206: S159-S165Kresfelder TL, Janssen R, Bont L, Venter M. Confirmation of an association between single nucleotide polymorphisms in the VDR gene with respiratory syncytial virus related disease in South African children. J Med Virol. 2011 Oct;83(10):1834-40. (Impact factor 2.8)

Venter M, van Niekerk S, Rakgantso A and Bent N. Identification of deletion mutant Respiratory Syncytial virus strains lacking 1 most of the G-protein in immunocompromised children with pneumonia in South Africa. J Virol. 2011 Aug;85(16):8453-7. Epub 2011 Jun 15. (Impact factor 5)

van Niekerk S and Venter M. Replacement of previously circulating Respiratory Syncytial Virus (RSV) subtype B strains with the BA genotype in South Africa. J Virol. 2011 Sep;85(17):8789-97. Epub 2011 Jun 29. (Impact factor 5)

Venter M, Human S, van Niekerk S, Williams J, van Eeden C and Freeman F. Emergence of lineage 1 West Nile virus in South Africa associated with fatal neurological disease and abortion in a horse. Emerging Infectious Diseases, Emerg Infect Dis. 2011 Aug;17(8):1534-6. (Impact factor 6)

Venter M, Lassaunière R, Kresfelder TL, Westerberg Y, Visser A. Contribution of common and recently described respiratory viruses to annual hospitalisations in children in South Africa. J Med Virol. 2011 Aug;83(8):1458-68. doi: 10.1002/jmv.22120. (Impact factor 2.8)

Van Kerkhove MD, Mounts AW, Sabine Mall, Katelijn A.H. Vandemaele, Chamberland M, Thais dos Santos, Fitzner J, Widdowson MA, Michalove J, Bresee J, Olsen SJ, Quick L, Baumeister E, Carlino L.O, Osvaldo Uez VS, Owen R, Ghani F,Paterson B, Forde A, Fasce R, Torres G, Andrade W, BustosP,  Mora J,Gonzalez C, Olea A, Sotomayor V, Manuel Najera De Ferrari, Alejandra Burgos, Darren Hunt, Sue Huang, Jennings LC, Macfarlane M, Lopez LD, McArthur C, Cohen C, Brett A, Blumberg L, Cengimbo A, Makunga C, McAnerney J, Msimang V, Naidoo D, Puren A, Schoub BD, Juno Thomas, Venter M for the WHO Southern Hemisphere Influenza Comparison Study Working Group, Epidemiologic and virologic assessment of the 2009 influenza A (H1N1) pandemic on selected temperate countries in the Southern Hemisphere: Argentina, Australia, Chile, New Zealand and South Africa. Influenza and Other Respiratory Viruses. Published online, 20 April 2011 DOI: 10.1111/j.1750-2659.2011.00249.x (Impact factor 3.8)

Blyth CC, Kelso A, McPhie KA, Ratnamohan VM, Catton M, Druce JD, Smith DW, Williams SH, Huang QS, Lopez L, Schoub BD, Venter M, DE Dwyer. The impact of the pandemic influenza A (H1N1) 2009 virus on seasonal influenza A viruses in the southern hemisphere, 2009. Euro surveillance, 2010 Aug 5; 15(31). pii: 19631. (Impact factor pending)

Berkley J.A, Munywoki P, Ngama M, Kazungu S, Abwao J, Bett A, Lassauniére R, Kresfelder T, Cane P, Venter M, Scott J.A.G, and Nokes D.J. Viral etiology of severe pneumonia among Kenyan young infants and children (JAMA. 2010 May 26;303(20):2051-7.) (Impact factor 30)

Venter M and Swanepoel R. Review: Pathogenesis of West Nile Virus lineage 2 as a cause of zoonotic neurological disease in humans and horses in Southern Africa. Vector born and zoonotic diseases, 2010 Oct;10(7):659-64. (Impact factor 2.7)

Lassauniére R., Kresfelder T., Venter M. A novel multiplex real-time RT-PCR assay with FRET hybridization probes for the detection and quantification of 13 traditional and newly identified respiratory viruses. (2010 Journal of Virological Methods May; 165(2):254-60. Epub 2010 Feb 11). (Impact factor 2.02)

Venter M*, Styel J, Wyers J, Blumberg L, Human S, Zaayman D, Swanepoel R. Zoonotic transmission of West Nile virus to a veterinarian during postmortem investigation of a horse with neurological symptoms. Emerging Infectious Diseases (Emerg Infect Dis. 2010 Mar; 16(3):573-5) (Impact factor 6).

Glass AJ, Venter M. Improved detection of JC virus in AIDS patients with progressive multifocal leukoencephalopathy by T-antigen specific fluorescence resonance energy transfer hybridization probe real-time PCR: evidence of diverse JC virus genotypes associated with progressive multifocal leukoencephalopathy in Southern Africa. J Med Virol. 2009 Nov; 81(11):1929-37 (Impact factor 2.8)

Archer BN, Cohen C, Naidoo D, Thomas J, Makunga C, Blumberg L, Venter M, Timothy GA, Puren A, McAnerney JM, Cengimbo A, Schoub BD. Interim report on pandemic H1N1 influenza virus infections in South Africa, April to October 2009: Epidemiology and factors associated with fatal cases. Euro Surveill.2009; 14(42): pii=19369.

Venter M, Blumberg L. The practitioners guide for dealing with the novel Influenza A, H1N1 pandemic. SA Family Practice 2009; 51:276-278.

Venter M, Human S, Zaayman D, Gerdes G.H,. Williams, J, Steyl, J, Leman, PA, Paweska J.T, Setzkorn, H, Rous G, Murray S, Parker R, Donnellan Cynthia, and Swanepoel, R. Lineage 2 West Nile Virus as Cause of Fatal Neurologic Disease in Horses, South Africa. Emerging Infectious Diseases. Volume 15, Number 6–June 2009 ;) (Impact factor 6)

Venter M*; Burt F.J, Leman P.A, Blumberg L, Fikl H, Paweska, J, Swanepoel R. Cytokine induction after laboratory-acquired West Nile virus infection.(New England Journal of Medicine. 2009 Mar 19;360(12):1260-2.).(Impact factor 51.2)

Venter, M* Visser A, Van den Bergh R. Human polyomaviruses, WU and KI in HIV exposed children with acute lower respiratory tract infections in hospitals in South Africa. Journal of Clinical Virology, 44 (2009) 230–234, (Impact Factor 3.4)

Zaayman D, Human S, Venter M*. A Highly Sensitive Method for the Detection and Genotyping of West Nile Virus by Real-Time PCR. J Virol Methods. 2009 May; 157(2):155-60. Epub 2009 Jan 10. (Impact factor 1.9)

Briese T, Renwick N, Venter M, Jarman RG, Ghosh D, Köndgen S, Sanjaya K, Shrestha A, Hoegh M, Casas Flecha I, Adjogoua EV, Akoua-Koffi C, Myint KS, Williams DT, Chidlow G, Van den Berg R, Calvo C, Koch O, Palacios G, Kapoor V, Villari J, Harnett G, Smith D, Mackenzie J, Ellerbrok H, Schweiger B, Schønning K, Chadha, MS, Leendertz FH, Mishra AC, Gibbons RV, Holmes EC, Lipkin WI. A recently identified picornavirus genotype contributes to acute respiratory disease worldwide. Journal of Emerging Infectious diseases, 2008, June). (Impact Factor 6)

Rakoto-Andrianarivelo M, Gumede NH, Balanant JJ, Rabemanantsoa NS, Birmingham M, Randriamanalina B, Nkolomoni L, Venter M, Schoub BD, Delpeyroux F, and Reynes JM. Re-emergence of Recombinant Vaccine-Derived Poliovirus Outbreak in Madagascar. 2008, J Infect Dis. 2008 Apr 11. (Impact factor, 5.3)

Visser A, Delport S, Venter M*. Molecular Epidemiological Analysis of a Nosocomial outbreak of Respiratory Syncytial Virus associated pneumonia in a Kangaroo Mother Care Unit in South Africa. Journal of Medical Virology, Journal of Medical Virology 2008; 80:724–732. (Impact factor, 2.8)).

Briese, T., G. Palacios, W. I. Lipkin, N. Renwick, Venter ,; Jarman R. G, Dominguez S. R., Holmes K. V., and Holmes E. C.. 2008. Prior Evidence of Putative Novel Rhinovirus Species, Australia Response. Emerging Infectious Diseases 14:1824-1825. (Impact Factor 6)

Botha EM, Markotter W, Wolfaardt M, Paweska JT, Swanepoel R, Palacios G, Nel LH, Venter M.* Genetic determinants of virulence in pathogenic lineage 2 west Nile virus strains. Emerg Infect Dis 2008; 14(2):222-30. (Impact factor 5.1)

Zhai J, Palacios G, Towner JS, Jabado O, Kapoor V, Venter M. Grolla G, Briese T, Paweska J, Swanepoel R, Feldmann F, Nichol ST, and Lipkin WI. A rapid molecular strategy for filovirus detection and characterization. Journal of Clinical Microbiology 45 (1): 224-226 JAN 2007) (Impact Factor, 3.4)

Palacios G, Briese T, Kapoor V, Jabado O, Liu Z, Venter M, Zhai J, Renwick N, Grolla A, Geisbert TW, Drosten C, Towner J, Ju J, Paweska J, Nichol S, Swanepoel R, Feldmann H, Jahrling P, and Lipkin IJ. Differential Diagnosis of Viral Hemorrhagic Fever by Mass Tag PCR. Emerging Infectious Diseases 12 (4): 692-695 APR 2006 2005 (Impact factor, 5.1)

Agenbach E, Tiemessen CT, Venter M*. Amino acid variation within the fusion protein of respiratory syncytial virus subtype A and B strains during annual epidemics in South Africa. Virus Genes, Vol. 30, No. 2, February, 2005. (Impact factor, 1.1)

Venter M*, Myers TG, Wilson MA, Kindt TJ, Paweska JT, Burt FJ, Leman PA, Swanepoel R. Gene expression in mice infected with West Nile virus strains of different neurovirulence. Virology 2005; 342(1):119-140 (Impact factor, 3.5)

Venter M*, Smit SB, Leman S and Swanepoel R. Phylogenetic evidence of widespread distribution of genotype 3 JC virus in Africa and identification of a type 7 isolate in an AIDS patient. (2004) J.Gen Virol, 2004 85 (8): p. 2215-2219. (Impact factor, 3.1)

Robertson SE, Roca A, Alonso P, Simoes EA, Kartasasmita CB, Olaleye DO, Odaibo GN, Collinson M, Venter M, Zhu Y, Wright PF. Respiratory syncytial virus infection: denominator-based studies in Indonesia, Mozambique, Nigeria and South Africa. Bull World Health Organ. 2004 Dec; 82(12):914-22.

Venter M*, Tiemessen CT, Crowe JE Jr. Respiratory Syncytial virus Nucleoprotein specific Cytotoxic T-cell epitopes in a South African population of diverse HLA types are conserved in circulating field strain. Journal of Virology, (2003), July, 77(13), p7319-29. (Impact factor, 5.3)

Madhi SA, Venter M, Madhi A, Petersen MK, Klugman KP. Differing manifestations of respiratory syncytial virus-associated severe lower respiratory tract infections in human immunodeficiency virus type 1-infected and uninfected children. Pediatr Infect Dis J 2001; 20(2):164-70. (Impact factor, 2.6).

Madhi SA, Venter M, Alexandra R, Lewis H, Kara Y, Karshagen WF, Greef M, Lassen C. Respiratory syncytial virus associated illness in high-risk children and national characterisation of the circulating virus genotype in South Africa. J Clin Virol. 2003 Jul; 27(2):180-9 (Impact Factor 3.4)

Venter M*, Collinson, M., Schoub B.D. Molecular epidemiological analysis of community circulating respiratory syncytial virus in rural South Africa: comparison of viruses and genotypes causing different disease manifestations. Journal of Medical Virology, 2002 Nov; 68(3):452-61. (Impact factor, 2.8)

Venter M*, Madhi SA, Tiemessen CT, Schoub BD. Genetic diversity and molecular epidemiology of respiratory syncytial virus over four consecutive seasons in South Africa: identification of new subgroup A and B genotypes. J Gen Virol 2001; 82(Pt 9):2117-24. (Impact factor, 3.1)

Madhi SA, Venter M, Madhi A, Petersen MK, Klugman KP. Differing manifestations of respiratory syncytial virus-associated severe lower respiratory tract infections in human immunodeficiency virus type 1-infected and uninfected children. Pediatr Infect Dis J 2001; 20(2):164-70. (Impact factor, 3.2)

Venter M, Napier G.and Huismans H.. Cloning, sequencing and expression of the gene that encodes the major neutralization- specific antigen of African horse sickness virus serotype 9. Journal of Virological methods 86 (2000) 41-53. (Impact factor, 2.09).